Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pfizer
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Bristol-Myers Squibb
Seagen Inc.
Genmab
Eli Lilly and Company
Pfizer
Dana-Farber Cancer Institute
PMV Pharmaceuticals, Inc
Merck Sharp & Dohme LLC
Verastem, Inc.
National Institutes of Health Clinical Center (CC)
Merck Sharp & Dohme LLC
IFOM ETS - The AIRC Institute of Molecular Oncology
Neonc Technologies, Inc.
Pfizer
Seagen Inc.
Tizona Therapeutics, Inc
Essen Biotech
Genentech, Inc.
Amgen
IDEAYA Biosciences
Novartis
Merck Sharp & Dohme LLC
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
ImmunityBio, Inc.
Eli Lilly and Company
Novartis
University of California, San Francisco
M.D. Anderson Cancer Center
Amgen
Sairopa B.V.
University of Pittsburgh
The Netherlands Cancer Institute
Curacell Holding AB
Twinpig Biolab, Inc.
National Cancer Centre, Singapore
Sotio Biotech Inc.
Eisai Inc.
Mirati Therapeutics Inc.
Eli Lilly and Company
Sanofi
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Tempest Therapeutics
Valo Therapeutics Oy
Epkin
Bicara Therapeutics